MYC and breast cancer: Recent CMT sequencing studies reported variants in genes such as BRCA1, TP53, USH2A, FOXC2, cMYC and in pathways such as PIK3-Akt, KRAS and HDR, as well as described molecular congruence of genes and pathways between BC and CMT [20–23].